A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a new study.

At the start of 2023, U.S. patent exclusivity expired for the blockbuster drug Humira, AbbVie's chief cash cow. During the 20 ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

Vascularized composite allotransplantation (VCA) has emerged as a well-established reconstructive method for treating tissue defects. Worldwide, more and more hand and upper extremity VCAs have been ...